4519.T

Fairly Valued

Chugai Pharmaceutical Co., Ltd. — PEG Ratio Analysis

1.90

PEG Ratio

1.90

Growth Rate Source

Good Data Quality5-Year EPS CAGR

Current Price

$7892.00

TTM EPS

$274.78

P/E Ratio

28.72

Growth Rate

15.1%

5-Year EPS CAGR

Sector

Healthcare

Drug Manufacturers - General

Calculated

6/17/2026

9:09:31 AM

Peer Comparison

Sample Size

3 peers

Industry Median PEG

0.70

25th Percentile

0.66

75th Percentile

0.85

4519.T PEG (1.90) vs Industry Median (0.70): 173% premium

Symbol	Company	PEG	P/E	Growth	vs 4519.T
4568.T	Daiichi Sankyo Company, Limited	0.66	19.2	29.1%	-65%
4503.T	Astellas Pharma Inc.	0.70	14.1	20.2%	-63%
4507.T	Shionogi & Co., Ltd.	0.85	12.4	14.7%	-55%

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.